Caris Life Sciences, Inc. (CAI)
23.07
-0.89
(-3.71%)
USD |
NASDAQ |
Nov 13, 10:06
Caris Life Sciences Free Cash Flow (Quarterly) : -39.72M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -39.72M |
| June 30, 2026 | 6.402M |
| March 31, 2026 | 22.53M |
| December 31, 2025 | 31.98M |
| September 30, 2025 | 55.33M |
| June 30, 2025 | 5.902M |
| Date | Value |
|---|---|
| March 31, 2025 | -34.03M |
| December 31, 2024 | -41.21M |
| September 30, 2024 | -71.26M |
| June 30, 2024 | -65.51M |
| March 31, 2024 | -75.66M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Natera, Inc. | 5.252M |
| Myriad Genetics, Inc. | -8.60M |
| BioRestorative Therapies, Inc. | -3.808M |
| CareDx, Inc. | 11.10M |
| Exagen, Inc. | -2.771M |